文献速递系统性红斑狼疮

利妥昔单抗与传统免疫抑制治疗膜性狼疮肾炎后免疫沉积物吸收对比

Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

电镜评分显示RTX后免疫复合物吸收现象增加(P=0.028),传统治疗无显著增加(P=0.29);临床应答者吸收现象更明显(P=0.022)。

要点

  • RTX治疗后肾活检电镜示免疫沉积物吸收现象增加(P=0.028),传统治疗无显著增加(P=0.29)。
  • 7例RTX中6例(86%)吸收增加,17例传统治疗中7例(41%)增加(P=0.047)。
  • 临床应答者免疫沉积物吸收较非应答者更明显(P=0.022)。

核心结论

  • 膜性狼疮肾炎重复肾活检可见免疫复合物吸收增加,尤其在RTX治疗后,且吸收现象与临床应答相关。

主要发现

  • 治疗后上皮下免疫复合物减少但未达显著,且两种治疗间无差异。
  • RTX后免疫复合物吸收现象增加(P=0.028),传统治疗后未显著增加(P=0.29)。
  • RTX组7例中6例(86%)吸收增加,传统治疗组17例中7例(41%)增加(P=0.047)。
  • 临床应答者免疫复合物吸收较非应答者更明显(P=0.022)。

关键数值与推荐

  • 电镜采用任意评分量表(0-3分)评估上皮下免疫复合物、免疫复合物吸收和足细胞融合水平。

临床怎么用

  • 电镜下的免疫复合物吸收现象可能有助于膜性狼疮肾炎的治疗评估,RTX在临床和组织层面均显示有效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Studies on repeat renal biopsies in membranous LN (MLN) are limited, and evaluation of treatment response is mainly based on proteinuria. EM of renal biopsies from rituximab (RTX)-treated MLN patients has revealed resorption of sub-epithelial ICs. Whether resorption phenomena are useful for treatment evaluation, or differs between treatment regimens is not known. We studied EM findings and clinical treatment response in MLN patients after RTX vs conventional immunosuppressive treatment. METHODS: Twenty-four patients with MLN and renal biopsies performed before and after treatment were included in this retrospective observational study. Laboratory data were collected at both biopsy occasions. Seven patients had received RTX and 17 had received conventional treatment (CYC, MMF or AZA). Electron micrographs of renal tissue were scored using an arbitrary scale (0-3) for the level of sub-epithelial ICs, resorption of ICs and podocyte fusion. RESULTS: Sub-epithelial ICs decreased after treatment, however not significantly and with no difference between treatments. The resorption phenomena increased after RTX (P = 0.028), but not after conventional therapy (P = 0.29). Six out of seven (86%) RTX-treated patients had increased resorption vs 7/17 (41%) after conventional therapies (P = 0.047). Clinical responders had more pronounced resorption of ICs vs non-responders (P = 0.022). CONCLUSIONS: We report increased resorption of ICs in repeat renal biopsies in MLN, especially after RTX treatment. Increased resorption phenomena were associated with clinical response, suggesting that EM findings may be useful for treatment evaluation in MLN. Although of limited size, the study indicates that RTX is effective both clinically and at a tissue level.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zickert A, Lannfelt K, Schmidt Mende J, et al. Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment. Rheumatology (Oxford). 2021. PMID: 33367774. doi:10.1093/rheumatology/keaa788

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。